← Eichor
Study identifier: NCT06203847 Synced from ClinicalTrials.gov · July 28, 2026
● Recruiting

The Effect of Prehospital Combination of Epinephrine, Vasopressin, and Steroid in OHCA

Condition: Cardiac Arrest · Out-Of-Hospital Cardiac Arrest · Emergency Medical Services  ·  Sponsor: National Taiwan University Hospital

PhaseNA
Planned participants1344
Who can joinAll sexes, 18 Years to no upper limit
Healthy volunteersNo

About this study

This project is a randomized controlled clinical research design, The hypothesis P-I-C-O of the study is: For adult patients in the Taipei City and New Taipei City communities who have suffered sudden non-traumatic death and have been resuscitated by advanced paramedics, the intervention group that receives combined drug treatment (epinephrine, vasopressin, methylprednisolone) has a better rate of sustained recovery of spontaneous circulation (ROSC) (primary outcome) and long-term survival status (secondary outcomes) compared to the control group that receives single drug treatment (epinephrine).

This description comes directly from the study's public registry record.

Talk to the study team

WEN CHU CHIANG, PhD  ·  +886 926131851  ·  drchiang.tw@gmail.com

Always discuss trial participation with your own doctor first.

Locations (1)

National Taiwan University HospitalTaipei, TaiwanRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT06203847